Related Experiment Video
Updated: Jan 28, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
NELFE-Dependent MYC Signature Identifies a Unique Cancer Subtype in Hepatocellular Carcinoma
Hien Dang1,2, Yotsawat Pomyen3,4, Sean P Martin3
1Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States. hien.dang@jefferson.edu.
Abstract:
The MYC oncogene is dysregulated in approximately 30% of liver cancer. In an effort to exploit MYC as a therapeutic target, including in hepatocellular carcinoma (HCC), strategies have been developed on the basis of MYC amplification or gene translocation. Due to the failure of these strategies to provide accurate diagnostics and prognostic value, we have developed a Negative Elongation Factor E (NELFE)-Dependent MYC Target (NDMT) gene signature. This signature, which consists of genes regulated by MYC and NELFE, an RNA binding protein that enhances MYC-induced hepatocarcinogenesis, is predictive of NELFE/MYC-driven tumors that would otherwise not be identified by gene amplification or translocation alone. We demonstrate the utility of the NDMT gene signature to predict a unique subtype of HCC, which is associated with a poor prognosis in three independent cohorts encompassing diverse etiologies, demographics, and viral status. The application of gene signatures, such as the NDMT signature, offers patients access to personalized risk assessments, which may be utilized to direct future care.
Insights
A new gene signature, the NDMT signature, identifies a unique subtype of liver cancer (HCC) driven by MYC and NELFE. This signature predicts poor prognosis and aids in personalized risk assessment for patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MYC oncogene dysregulation is common in liver cancer, particularly hepatocellular carcinoma (HCC).
- Current diagnostic and prognostic strategies based on MYC amplification or translocation are insufficient.
- Hepatocarcinogenesis is enhanced by the RNA binding protein NELFE in conjunction with MYC.
Purpose of the Study:
- To develop a novel gene signature for identifying MYC/NELFE-driven HCC subtypes.
- To assess the diagnostic and prognostic utility of this new signature.
- To enable personalized risk assessment and guide future patient care.
Main Methods:
- Development of a Negative Elongation Factor E (NELFE)-Dependent MYC Target (NDMT) gene signature.
- Analysis of gene expression data from three independent HCC cohorts.
- Validation of the NDMT signature's predictive capability for patient prognosis.
Main Results:
- The NDMT gene signature effectively identifies a unique HCC subtype not detectable by traditional methods.
- This specific HCC subtype is associated with a poor prognosis across diverse patient cohorts.
- The signature's predictive power was validated in independent datasets with varying etiologies and demographics.
Conclusions:
- The NDMT gene signature offers a more accurate diagnostic and prognostic tool for a subset of HCC.
- This signature facilitates the identification of NELFE/MYC-driven tumors.
- Application of the NDMT signature can lead to improved personalized risk stratification for HCC patients.
Related Concept Videos
Other Unique Bacteria
Second Uniqueness Theorem
In contrast, consider that the electric field is non-unique and apply Gauss's law in divergence form in the region between the conductors and the integral form to the surface...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Frequency-dependent Selection

